N
NGEN
Nervgen Pharma Corp
2.000
+0.140+7.53%After Hours: 1.999 -0.001 -0.06%19:30 08/24 EDT
OPEN/PREV CLOSE1.980/2.000
TODAY RANGE1.960-2.105
VOL8.27K
MARKET CAP223.65M
52 WEEK RANGE1.580-6.30
AVG VOL (3M)731.93K
% TURNOVER0.85%
TURNOVER153.36K
P/E (TTM)-3.8879
% RANGE7.25%
EPS(TTM)-0.5350
P/E(FORWARD)-4.0000
P/B18.20
BVPS0.1143
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP188.68M
SHARES OUTSTANDING107.52M
NEXT EARNINGS11/23-11/27
FREE FLOAT90.71M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/17 07:59
NervGen Pharma reports Q2 EPS (C$0.37) vs. (C$0.13) last year
TipRanks·08/13 12:01
NervGen Pharma Posts Larger Q2 2026 Loss but Strengthens Cash Position
Seeking Alpha·08/13 11:41
NervGen Pharma GAAP EPS of -C$0.37
Dow Jones·08/13 11:32
*NervGen Pharma 2Q Loss/Shr C$0.32 >NGEN
Benzinga·07/14 12:19
Micron To Rally Around 87%? Here Are 10 Top Analyst Forecasts For Tuesday
Dow Jones·07/14 10:28
NervGen Pharma Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·07/14 10:28
NervGen Pharma Price Target Cut to $15.00/Share From $18.00 by HC Wainwright & Co.
Benzinga·07/14 10:19
HC Wainwright & Co. Maintains Buy on NervGen Pharma, Lowers Price Target to $15
TipRanks·07/14 10:00
NervGen Pharma price target lowered to $15 from $18 at H.C. Wainwright
Dow Jones·07/13 18:09
NervGen Pharma Price Target Announced at $10.00/Share by Leerink Partners
TipRanks·07/13 11:45
NervGen Pharma initiated with an Outperform at Leerink
Seeking Alpha·07/06 12:45
United Therapeutics Vs. Regencell Bioscience: I Choose Profits Over Promises
TipRanks·07/02 21:47
NervGen Pharma Sets Up US$50 Million ATM Equity Program With Leerink Partners
Seeking Alpha·07/02 16:25
NervGen Pharma: I Think The Biggest Risks Are Now Behind It
Same Industry
Name/Symbol
Change%
Price